EurekaMag.com logo
+ Site Statistics
References:
54,215,046
Abstracts:
30,230,908
PMIDs:
28,215,208
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model



Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model



Cell Metabolism 5(5): 331-344



WNK1 and WNK4 mutations have been reported to cause pseudohypoaldosteronism type II (PHAII), an autosomal-dominant disorder characterized by hyperkalemia and hypertension. To elucidate the molecular pathophysiology of PHAII, we generated Wnk4(D561A/+) knockin mice presenting the phenotypes of PHAII. The knockin mice showed increased apical expression of phosphorylated Na-Cl cotransporter (NCC) in the distal convoluted tubules. Increased phosphorylation of the kinases OSR1 and SPAK was also observed in the knockin mice. Apical localization of the ROMK potassium channel and transepithelial Cl(-) permeability in the cortical collecting ducts were not affected in the knockin mice, whereas activity of epithelial Na(+) channels (ENaC) was increased. This increase, however, was not evident after hydrochlorothiazide treatment, suggesting that the regulation of ENaC was not a genetic but a secondary effect. Thus, the pathogenesis of PHAII caused by a missense mutation of WNK4 was identified to be increased function of NCC through activation of the OSR1/SPAK-NCC phosphorylation cascade.

(PDF emailed within 0-6 h: $19.90)

Accession: 013763184

Download citation: RISBibTeXText

PMID: 17488636

DOI: 10.1016/j.cmet.2007.03.009



Related references

Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade. Journal of Cell Science 124(Pt 9): 1391-1395, 2011

Molecular Pathogenesis of Congenital Hypertensive Disease - Pseudohypoaldosteronism Type II and WNK4. Nihon Naika Gakkai Zasshi 98(7): 1720-1725, 2009

WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3. Biochemical and Biophysical Research Communications 491(3): 727-732, 2017

Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain. Faseb Journal 201801023r-Fj201801023r, 2018

Generation and analysis of the thiazide-sensitive Na+ -Cl- cotransporter (Ncc/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome. Human Mutation 31(12): 1304-1315, 2011

Identification of a novel WNK4 mutation in Chinese patients with pseudohypoaldosteronism type II. Nephron. Physiology 118(3): P53-P61, 2012

A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine 33(3): 230-234, 2008

Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene. Qjm 105(8): 791-794, 2013

Mechanisms for hypercalciuria in pseudohypoaldosteronism type II-causing WNK4 knock-in mice. Endocrinology 151(4): 1829-1836, 2010

A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. Hypertension 46(2): 295-300, 2005

Molecular pathogenesis of renal pseudohypoaldosteronism type 1. Expert Review of Endocrinology & Metabolism 2(3): 407-419, 2007

Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proceedings of the National Academy of Sciences of the United States of America 100(2): 680-684, 2003

Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6. Proceedings of the National Academy of Sciences of the United States of America 109(43): 17693-8, 2013

The first knockin mouse model of episodic ataxia type 2. Experimental Neurology 261: 553-562, 2014

Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1. Journal of Clinical Endocrinology and Metabolism 91(11): 4552-4561, 2006